{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:49:23Z","timestamp":1782121763705,"version":"3.54.5"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cystic lymphatic malformations (CLMs) with intracapsular hemorrhage present a management challenge. This study aimed to describe and compare the clinical outcomes associated with pingyangmycin\u2013polidocanol foam (PPF) versus pingyangmycin (PYM) sclerotherapy in this pediatric population. A retrospective cohort study was conducted on 74 pediatric patients with CLMs and intracapsular hemorrhage treated between October 2020 and May 2023. Patients were treated with either PPF (n\u2005=\u200537) or PYM (n\u2005=\u200537). The primary outcomes were lesion volume reduction grading, number of treatment sessions, pain relief, and family satisfaction. Secondary outcomes included adverse effects and recurrence. Factors associated with treatment response were explored. Baseline characteristics were comparable between groups. Children in the PPF group exhibited a greater median reduction in lesion volume after the first session (23.0\u2009cm\n                      <jats:sup>3<\/jats:sup>\n                      vs 12.2\u2009cm\n                      <jats:sup>3<\/jats:sup>\n                      ,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.028) and received fewer median treatment sessions (2 vs 3,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.023) compared with those in the PYM group. A higher proportion in the PPF group achieved a good response (Achauer grade III\/IV) after the final treatment (83.8% vs 73.0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.020) and reported complete pain relief (73.6% vs 41.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.036). Family satisfaction scores were significantly higher in the PPF group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.020). There were no significant differences in overall adverse event rates (18.9% vs 27.0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.407) or recurrence rates (21.6% vs 27.0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.787). Multivariable analysis confirmed that PPF treatment and macrocystic\/mixed lesion type were independent factors associated with a good response. An increased number of treatment sessions was associated with more adverse effects but lower recurrence. In this retrospective analysis, PPF sclerotherapy was associated with a greater initial volume reduction, fewer treatment sessions, and higher family satisfaction compared with PYM alone in pediatric CLMs with intracapsular hemorrhage. Macrocystic and mixed lesions showed better response to PPF. Prospective studies are warranted to validate these findings.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048567","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:01:00Z","timestamp":1777629660000},"page":"e48567","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcome of pingyangmycin\u2013polidocanol foam versus pingyangmycin alone in pediatric cystic lymphatic malformation with intracapsular hemorrhage: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Shuting","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Intervention and Hemangioma, Capital Center for Children\u2019s Health, Capital Medical University, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Intervention and Hemangioma, Capital Center for Children\u2019s Health, Capital Medical University, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2509-0434","authenticated-orcid":false,"given":"Gang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Intervention and Hemangioma, Capital Center for Children\u2019s Health, Capital Medical University, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"735832","DOI":"10.3389\/fped.2021.735832","article-title":"Recent progress in lymphangioma.","volume":"9","author":"Liu","year":"2021","journal-title":"Front Pediatr"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00383-016-3867-4","article-title":"Pediatric lymphatic malformations: evolving understanding and therapeutic options.","volume":"32","author":"Defnet","year":"2016","journal-title":"Pediatr Surg Int"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.sempedsurg.2014.07.002","article-title":"Lymphatic malformations: diagnosis and management.","volume":"23","author":"Elluru","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.oraloncology.2011.08.001","article-title":"Treatment guidelines of lymphatic malformations of the head and neck.","volume":"47","author":"Zhou","year":"2011","journal-title":"Oral Oncol"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"100631","DOI":"10.1016\/j.tvir.2019.100631","article-title":"Common (cystic) lymphatic malformations: current knowledge and management.","volume":"22","author":"Dubois","year":"2019","journal-title":"Tech Vasc Interv Radiol"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"150971","DOI":"10.1016\/j.sempedsurg.2020.150971","article-title":"Lymphatic malformations.","volume":"29","author":"Kulungowski","year":"2020","journal-title":"Semin Pediatr Surg"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0032-1329934","article-title":"Management of head and neck lymphatic malformations.","volume":"28","author":"Balakrishnan","year":"2012","journal-title":"Facial Plast Surg"},{"key":"R8-20260622","first-page":"CD013000","article-title":"Interventions for orbital lymphangioma.","volume":"5","author":"Patel","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.suc.2012.03.016","article-title":"Vascular anomalies in pediatrics.","volume":"92","author":"Fevurly","year":"2012","journal-title":"Surg Clin North Am"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/jiaps.JIAPS_94_20","article-title":"Results of injection sclerotherapy with bleomycin in pediatric lymphatic malformations.","volume":"26","author":"Kumar","year":"2021","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jpedsurg.2024.01.023","article-title":"Efficacy of bleomycin-lauromacrogolfoam in pediatric macrocystic lymphatic malformations with and without intracapsular hemorrhage.","volume":"59","author":"Wang","year":"2024","journal-title":"J Pediatr Surg"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.otohns.2007.11.018","article-title":"Nonsurgical therapies for lymphangiomas: a systematic review.","volume":"138","author":"Acevedo","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"e4790","DOI":"10.1097\/MD.0000000000004790","article-title":"Treatment of deep-seated facial microcystic lymphatic malformations with intralesional injection of pingyangmycin.","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"101698","DOI":"10.1016\/j.jvsv.2023.101698","article-title":"Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.","volume":"12","author":"Guzelbey","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejvs.2020.01.023","article-title":"Bleomycin polidocanol foam (BPF) stability \u2013 in vitro evidence for the effectiveness of a novel sclerosant for venous malformations.","volume":"59","author":"Sun","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/02683555231184772","article-title":"Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin.","volume":"38","author":"Yang","year":"2023","journal-title":"Phlebology"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/lrb.2021.0053","article-title":"Successful sclerotherapy for cervicofacial macrocystic lymphatic malformations using polidocanol and pingyangmycin combined foam sclerosants.","volume":"20","author":"Wang","year":"2022","journal-title":"Lymphat Res Biol"},{"key":"R18-20260622","first-page":"65","article-title":"Effect of hemorrhage of large cystic lymphatic malformation on therapeutic efficacy of sclerotherapy in children.","volume":"20","author":"X","year":"2021","journal-title":"J Clin Pediatr Surg"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ijom.2017.12.004","article-title":"Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series.","volume":"47","author":"Ribeiro","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/neurintsurg-2015-012255","article-title":"Guidelines and parameters: percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations.","volume":"9","author":"Heit","year":"2017","journal-title":"J Neurointerv Surg"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"6010458","DOI":"10.1155\/2022\/6010458","article-title":"A retrospective study of lip hemangiomas: curative effect of oral propranolol combined with topical sclerotherapy.","volume":"2022","author":"Ling","year":"2022","journal-title":"Biomed Res Int"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2147\/CCID.S386813","article-title":"Sclerotherapy in lymphatic malformations with intralesional hemorrhage: a retrospective comparison with non-hemorrhagic lymphatic malformations.","volume":"15","author":"Wang","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14639\/0392-100X-N1310","article-title":"Sclerotherapy with polidocanol microfoam in head and neck venous and lymphatic malformations.","volume":"42","author":"De Corso","year":"2022","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"935470","DOI":"10.3389\/fped.2022.935470","article-title":"Efficacy and safety of ultrasound-guided bleomycin combined with dexamethasone in the treatment of pediatric lymphangiomas.","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Pediatr"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"925318","DOI":"10.3389\/fped.2022.925318","article-title":"Effectiveness of polidocanol in the treatment of venous malformations: a meta-analysis.","volume":"10","author":"Liu","year":"2022","journal-title":"Front Pediatr"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MOP.0000000000000209","article-title":"Management of lymphatic malformations in children.","volume":"27","author":"Bagrodia","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.avsg.2025.07.049","article-title":"Advances in sclerosants for low-flow vascular malformations.","volume":"122","author":"Sun","year":"2026","journal-title":"Ann Vasc Surg"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bjps.2015.10.045","article-title":"Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents.","volume":"69","author":"Horbach","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s40001-022-00844-3","article-title":"A nomogram for predicting sclerotherapy response for treatment of lymphatic malformations in children.","volume":"27","author":"Wu","year":"2022","journal-title":"Eur J Med Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:09:26Z","timestamp":1782119366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048567","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2024-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}